A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment

被引：0
作者：
Yin, Y. [1 ]
Tang, S. [2 ]
Shen, C. [1 ]
Zhang, B. [2 ]
机构：
[1] West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-088
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
[21]   Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile? [J].
Tielen, Ronald ;
Verhoef, Cornelis ;
van Coevorden, Frits ;
Gelderblom, Hans ;
Sleijfer, Stefan ;
Hartgrink, Henk H. ;
Bonenkamp, Johannes J. ;
van der Graaf, Winette T. ;
de Wilt, Johannes H. W. .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
[22]   Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors:A meta-analysis [J].
Ping Chen .
World Journal of Gastroenterology, 2010, 16 (33) :4227-4232
[23]   Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors [J].
Ogata, Kyoichi ;
Kimura, Akiharu ;
Nakazawa, Nobuhiro ;
Suzuki, Masaki ;
Yanoma, Toru ;
Ubukata, Yasunari ;
Iwamatsu, Kiyohito ;
Kogure, Norimichi ;
Yanai, Mitsuhiro ;
Kuwano, Hiroyuki .
DIGESTION, 2018, 97 (01) :20-25
[24]   Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs) [J].
Sym, Sun Jin ;
Ryu, Min-Hee ;
Lee, Jae-Lyun ;
Chang, Heung Moon ;
Kim, Tae-Won ;
Kim, Hee Cheol ;
Kim, Ki Hun ;
Yook, Jeong Hwan ;
Kim, Byung Sik ;
Kang, Yoon-Koo .
JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (01) :27-33
[25]   Surgical resection after imatinib treatment in patients with metastatic or unresectable gastrointestinal stromal tumors [J].
Ryu, Min-Hee ;
Lee, Jae-Lyun ;
Chang, Heung Moon ;
Kim, Tae Won ;
Kim, Hee Cheol ;
Yook, Jeong Hwan ;
Yu, Chang Sik ;
Kim, Byung Sik ;
Kim, Jin Cheon ;
Kang, Yoon-Koo .
ANNALS OF ONCOLOGY, 2006, 17 :164-164
[26]   Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib [J].
Bauer, S ;
Hartmann, JT ;
de Wit, M ;
Lang, H ;
Grabellus, F ;
Antoch, G ;
Niebel, W ;
Erhard, J ;
Ebeling, P ;
Zeth, M ;
Taeger, G ;
Seeber, S ;
Flasshove, M ;
Schütte, J .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) :316-325
[27]   Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile? [J].
Ronald Tielen ;
Cornelis Verhoef ;
Frits van Coevorden ;
Hans Gelderblom ;
Stefan Sleijfer ;
Henk H Hartgrink ;
Johannes J Bonenkamp ;
Winette T van der Graaf ;
Johannes H W de Wilt .
World Journal of Surgical Oncology, 10
[28]   Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors: A meta-analysis [J].
Chen, Ping ;
Zong, Liang ;
Zhao, Wei ;
Shi, Lei .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (33) :4227-4232
[29]   Imatinib discontinuation in patients with metastatic gastrointestinal stromal tumors (GISTs) [J].
de Pas, Tommaso ;
Biffi, Roberto ;
Mazzarol, Giovanni ;
Della Vigna, Paolo ;
Travaini, Laura ;
Curigliano, Giuseppe ;
Formica, Vincenzo ;
de Braud, Filippo .
ANNALS OF ONCOLOGY, 2004, 15 :201-201
[30]   Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors [J].
Farag, Sheima ;
Verschoor, Arjan J. ;
Bosma, Jacob W. ;
Gelderblom, Hans ;
Kerst, J. Martijn ;
Sleijfer, Stefan ;
Steeghs, Neeltje .
JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (08) :920-925
12345